Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India

Susheel Kumar Yeshala, Soumya Surath Panda, Lalatendu Moharana, SV Saju, Krishnakumar Rathinam, Susan Honey Raju, Amit Sehrawat, Deepak Sundriyal, Ashwin Oommen Phillip, Pamela Alice Kinsely, Kanu Priya Bhatia, Smita Kayal, Biswajit Dubashi, Sunu Lazar Cyriac, Sathya Natarajan, Lipsita Samantaray, Swati Sucharita Mohanty, Sudam Sadangi, Snehasis Pradhan, Arti Rana, Prasanth Ganesan

Open source

DOI: 10.1186/s13048-026-02021-0
Published: 2026-02-07
Container: Journal of Ovarian Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13048-026-02021-0,
  title = {Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India},
  author = {Susheel Kumar Yeshala and Soumya Surath Panda and Lalatendu Moharana and SV Saju and Krishnakumar Rathinam and Susan Honey Raju and Amit Sehrawat and Deepak Sundriyal and Ashwin Oommen Phillip and Pamela Alice Kinsely and Kanu Priya Bhatia and Smita Kayal and Biswajit Dubashi and Sunu Lazar Cyriac and Sathya Natarajan and Lipsita Samantaray and Swati Sucharita Mohanty and Sudam Sadangi and Snehasis Pradhan and Arti Rana and Prasanth Ganesan},
  year = {2026},
  journal = {Journal of Ovarian Research},
  doi = {10.1186/s13048-026-02021-0},
  url = {https://doi.org/10.1186/s13048-026-02021-0}
}

RIS

TY  - JOUR
TI  - Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India
AU  - Susheel Kumar Yeshala
AU  - Soumya Surath Panda
AU  - Lalatendu Moharana
AU  - SV Saju
AU  - Krishnakumar Rathinam
AU  - Susan Honey Raju
AU  - Amit Sehrawat
AU  - Deepak Sundriyal
AU  - Ashwin Oommen Phillip
AU  - Pamela Alice Kinsely
AU  - Kanu Priya Bhatia
AU  - Smita Kayal
AU  - Biswajit Dubashi
AU  - Sunu Lazar Cyriac
AU  - Sathya Natarajan
AU  - Lipsita Samantaray
AU  - Swati Sucharita Mohanty
AU  - Sudam Sadangi
AU  - Snehasis Pradhan
AU  - Arti Rana
AU  - Prasanth Ganesan
PY  - 2026
JO  - Journal of Ovarian Research
DO  - 10.1186/s13048-026-02021-0
UR  - https://doi.org/10.1186/s13048-026-02021-0
ER  -

APA

Yeshala, S. K., Panda, S. S., Moharana, L., Saju, S., Rathinam, K., Raju, S. H., Sehrawat, A., Sundriyal, D., Phillip, A. O., Kinsely, P. A., Bhatia, K. P., Kayal, S., Dubashi, B., Cyriac, S. L., Natarajan, S., Samantaray, L., Mohanty, S. S., Sadangi, S., Pradhan, S., Rana, A., & Ganesan, P. (2026). Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02021-0

Source records

crossref · retrieved 2026-09-26T12:59:25.410Z